Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mark Leschly currently holds 427,517 shares of NGM BIOPHARMACEUTICALS INC (NGM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark Leschly has been a net buyer of NGM stock. They have purchased $26.7M and sold $1.2M worth of shares.
Mark Leschly's most recent insider trade was on Jul 8, 2025, when they sold 254,785 shares at $0.00 per share.
Mark Leschly serves as Executive at NGM BIOPHARMACEUTICALS INC (NGM). They have executed 48 insider transactions totaling $27.9M over their tenure at the company.
Mark Leschly holds the position of Executive at NGM BIOPHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Mark Leschly has shown a buying trading pattern, with $26.7M in total purchases and $1.2M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Mark Leschly was on Dec 3, 2016, when they sold $46.2M worth of EVDY shares. This transaction involved 4,397,630 shares at $10.50 per share.
Mark Leschly currently owns 427,517 shares of NGM BIOPHARMACEUTICALS INC (NGM), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mark Leschly's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mark Leschly has 48 Form 4 filings on record as an insider at NGM BIOPHARMACEUTICALS INC.
Set alerts for Mark Leschly and 40,000+ other insiders.